Clinical Trial Update: High-dose Intravenous Methotrexate Versus Intrathecal Methotrexate for Central Nervous System Prophylaxis in DLBCL [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares high-dose intravenous methotrexate with intrathecal methotrexate for central nervous system prophylaxis in diffuse large B-cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Chonnam National University Hospital | Conditions: DLBCL | Phase 3 | Status: UNKNOWN